Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease

Abstract

Cell stress and impaired oxidative phosphorylation are central to mechanisms of synaptic loss and neurodegeneration in the cellular pathology of Alzheimer’s disease (AD). In this study, we quantified the in vivo expression of the endoplasmic reticulum stress marker, sigma 1 receptor (S1R), using [ 11 C]SA4503 positron emission tomography (PET), the mitochondrial complex I (MC1) with [ 18 F]BCPP-EF, and the presynaptic vesicular protein SV2A with [ 11 C]UCB-J in 12 patients with early AD and in 16 cognitively normal controls. We integrated these molecular measures with assessments of regional brain volumes and cerebral blood flow (CBF) measured with magnetic resonance imaging arterial spin labeling. Eight patients with AD were followed longitudinally to estimate the rate of change of the physiological and structural pathology markers with disease progression. The patients showed widespread increases in S1R (≤ 27%) and regional reduction in MC1 (≥ −28%) and SV2A (≥ −25%) radioligand binding, brain volume (≥ −23%), and CBF (≥ −26%). [ 18 F]BCPP-EF PET MC1 binding (≥ −12%) and brain volumes (≥ −5%) showed progressive reductions over 12 to 18 months, suggesting that they both could be used as pharmacodynamic indicators in early-stage therapeutics trials. Associations of reduced MC1 and SV2A and increased S1R radioligand binding with reduced cognitive performance in AD, although exploratory, suggested a loss of metabolic functional reserve with disease. Our study thus provides in vivo evidence for widespread, clinically relevant cellular stress and bioenergetic abnormalities in early AD.

Protein Kinase N2 Reduces Hydrogen Peroxide-inducedDamage and Apoptosis in PC12 Cells by AntiOxidative Stress and Activation of the mTOR Pathway

“…Diseases of the central nervous system often manifest as neuronal death. ere is increasing evidence that oxidative stress is important pathogenesis of many central nervous system diseases [16][17][18]. erefore, inhibiting oxidative stress can reduce neuronal damage, which is of positive significance for the prevention and treatment of neurological diseases.…”

Automated brain image analysis in dementia using artificial intelligence: a roadmap for the development of clinical tools

“…Neuroimaging is particularly important in dementia for corroborating the presence of a neurodegenerative process, ruling out alternative diagnoses, and for detailed stratification of disease and subtype [15][16][17]. Imaging based biomarkers are used in clinical trials to aid recruitment and to assess efficacy as secondary endpoints.…”

Galangin Rescues Alzheimer’s Amyloid-β Induced Mitophagy and Brain Organoid Growth Impairment

“…Accumulating evidence suggests that mitochondria, the main energy-producing organelles in cells, play a critical role in the development of Alzheimer’s disease (AD). Mitochondria impairment has been shown to occur in early AD patients, potentially contributing to brain cell death and inflammation, which are hallmarks of Alzheimer’s disease [ 1 ]. Mitophagy is the process by which cells remove and recycle impaired mitochondria.…”